Danaparoid: a review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. (vol 54, pg 903, 1997)

被引：2
|
作者：
Wilde, MI
Markham, A
机构：
来源：
DRUGS | 1998年 / 55卷 / 04期
关键词：
D O I：
10.1007/BF03259986
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [41] Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
    Brigitte Tardy-Poncet
    Philippe Nguyen
    Jean-Claude Thiranos
    Pierre-Emmanuel Morange
    Christine Biron-Andréani
    Yves Gruel
    Jérome Morel
    Alain Wynckel
    Lelia Grunebaum
    Judith Villacorta-Torres
    Sandrine Grosjean
    Emmanuel de Maistre
    Critical Care, 19
  • [42] Pathophysiology of heparin-induced thrombocytopenia clinical and diagnostic implications - A review
    Fabris, F
    Ahmad, S
    Cella, G
    Jeske, WP
    Walenga, JM
    Fareed, J
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (11) : 1657 - 1666
  • [43] The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage
    Hertle, Daniel N.
    Haehnel, Stefan
    Richter, Goetz M.
    Unterberg, Andreas
    Sakowitz, Oliver W.
    Kiening, Karl L.
    BRITISH JOURNAL OF NEUROSURGERY, 2011, 25 (01) : 117 - 119
  • [44] Clinical usefulness of three assays for the laboratory diagnosis of documented heparin-induced thrombocytopenia. Is there a gold standard?
    Walenga, JM
    Fasanella, AR
    Jeske, WP
    Zaman, S
    Aranha, R
    Bakhos, M
    CIRCULATION, 1997, 96 (08) : 213 - 213
  • [45] Heparin-induced thrombocytopenia type 2: evaluation of the relevance of danaparoid sodium (Orgaran®) use in a French university hospital
    Lepelley, M.
    Gibert, P.
    Brudieu, E.
    Mallaret, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 36 - 36
  • [46] Heparin-induced thrombocytopenia and cardiac surgery (vol 76, pg 638, 2003)
    Warkentin, TE
    Greinacher, A
    ANNALS OF THORACIC SURGERY, 2003, 76 (06): : 2121 - 2131
  • [47] Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia
    Albuloushi, Asmaa
    Rhoten, Megan
    Kelly, Julie
    Sylvester, Katelyn W.
    Grandoni, Jessica
    Connors, Jean M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 597 - 604
  • [48] The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: An update
    Prechel, Margaret
    Walenga, Jeanine M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (01): : 86 - 96
  • [49] Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia
    Raschke, R. A.
    Gallo, T.
    Curry, S. C.
    Whiting, T.
    Padilla-Jones, A.
    Warkentin, T. E.
    Puri, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) : 1640 - 1645
  • [50] Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia
    Asmaa Albuloushi
    Megan Rhoten
    Julie Kelly
    Katelyn W. Sylvester
    Jessica Grandoni
    Jean M. Connors
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 597 - 604
12345